Intensity Therapeutics raises $6.6M from ATM stock sales in July

Intensity Therapeutics (INTS) announces that in July, the company added $6.6M in gross proceeds by selling 19,868,658 shares of its common stock via its At-the-Market offering at an average price of 33.23c per share. Following such sales of common stock pursuant to the ATM, the company has 46,035,081 shares of common stock issued and outstanding as of July 31. “We were able to take advantage of strong liquidity and favorable prices in our stock last month. The proceeds from these ATM sales strengthen our balance sheet considerably and allow us to continue to advance the clinical trials into the second half of 2026,” said Lewis Bender, President and CEO of Intensity. “We are also pleased to announce that the average price per share for these ATM sales was more than 10% higher than our recently completed June 2025 public offering, and the costs to raise this incremental capital were much lower. We will continue to be selective and strategic in the deployment of the remainder of the ATM.”